Human milk contains plasmalogens, they sit in the milk fat globule membrane, and they accumulate in the infant brain. Those three facts are well established and they make an obvious marketing story. The research itself is more careful than the story, and in one important respect it points the other way: the study that looked hardest for a link between breast milk plasmalogen levels and infant neurodevelopment did not find one. This page reports what was measured. It is not a page about supplements, and no plasmalogen supplement described anywhere on this site is intended for an infant or for a nursing mother.
Key Takeaways
- Ethanolamine plasmalogens are a normal constituent of the milk fat globule membrane in human milk, with C18:0 vinyl ethers and C18:2 enriched species predominating.
- Measured concentrations vary enormously between mothers. In a French cohort of 22 women, milk plasmalogen ranged from 3.4 to 39.2 mg per litre, more than a tenfold spread.
- In 39 mother and infant pairs, milk plasmalogen levels fell between one month and four months postpartum, and higher levels at one month were associated with lower infant fat mass and higher lean mass.
- That same study reported that milk plasmalogen concentrations were not correlated with infant neurodevelopmental outcomes, which is the opposite of the claim usually attached to this topic.
- A separate observational study of 65 children found human milk phospholipids broadly associated with preschool cognitive scores, with plasmalogens specifically linked to one subdomain in one sampling window. That is a narrow finding, not a general one.
Where Plasmalogens Sit in Milk
Milk fat is delivered as globules wrapped in a membrane derived from the mammary epithelial cell, and that milk fat globule membrane is where the phospholipids live, including ethanolamine plasmalogens. These carry a vinyl ether at the sn-1 position and a polyunsaturated fatty acid at sn-2, the same structure described in our explainer on what plasmalogens are, and they are known to accumulate in the developing infant brain. Human milk is therefore one of the few dietary sources of plasmalogens that essentially every person consumes at some point, which is a different question from the adult dietary sources covered separately.
How Much Varies, and It Varies a Lot
A 2011 study collected milk from 22 lactating women in Marseille and measured triglycerides, total phospholipids, plasmalogens, fatty acid profile and cholesterol. The headline of that paper was a docosahexaenoic acid shortfall: depending on which guideline was applied, either 46% or 82% of samples fell below the recommended DHA level, and most showed high linoleic to alpha-linolenic acid ratios. The plasmalogen measurement was secondary, and what it showed was range. Milk plasmalogen levels ran from 3.4 to 39.2 mg per litre across the cohort[1].
A more than tenfold spread between healthy mothers in a single city is the first thing anyone should know about this topic. It means a single average figure quoted for the plasmalogen content of human milk conveys very little, and it means comparisons between milk and any manufactured alternative depend heavily on which mothers were sampled.
The Study That Looked for a Neurodevelopment Link
The most detailed study of this question is a secondary analysis of 39 mother and infant pairs drawn from the control arm of a randomised trial of vitamin D supplementation during lactation. Milk was sampled and analysed by ultra high performance liquid chromatography with high resolution tandem mass spectrometry at one month and again at four months postpartum, with infant body composition measured by dual-energy X-ray absorptiometry and infant development assessed at both visits[2].
Its findings were mixed and specific. C18:0 vinyl ethers and C18:2 enriched ethanolamine plasmalogens predominated. Specific species declined as a proportion of total phospholipid between one and four months. Higher maternal body mass index was associated with lower milk plasmalogens in unadjusted models, but that association was attenuated once race, diet and days postpartum were accounted for, so it should not be reported as an established effect of maternal BMI. Total plasmalogens at one month were negatively associated with infant fat mass index and positively associated with fat-free mass index.
And then the result that matters most for how this topic gets marketed: milk plasmalogen concentrations were not correlated with infant neurodevelopmental outcomes in this cohort. The authors state the implication in terms of body composition, lower adiposity and higher lean mass, not in terms of cognition. Anyone citing this study as evidence that milk plasmalogens support infant brain development is citing it for a finding it reports the absence of.
The Preschool Cognition Study, in Proportion
A 2025 observational study within the maternal nutrition and infant investigation cohort took a longer view, linking measured human milk phospholipid concentrations to cognitive assessment in preschool-aged children using the Griffiths Mental Development Scales. Sixty-five children had both milk and cognitive data, split by when the milk was sampled: 27 at 40 to 45 days postpartum and 38 at 200 to 400 days[3].
In the earlier sampling window, no phospholipid class was significantly associated with developmental quotient. In the later window, phosphatidylethanolamine and phosphatidylcholine concentrations were positively associated with the personal and social subdomain, with phosphatidylethanolamine also associated with hand-eye coordination. Plasmalogens specifically, alongside odd-chain fatty acid containing phospholipids, were associated with the personal and social subdomain only.
That is a real finding and a narrow one. It is observational, the sample is 65 children split into two groups of 27 and 38, the association for plasmalogens covers one subdomain in one sampling window, and the study cannot separate the phospholipid content of milk from everything else that differs between families who breastfeed longer. The authors frame their conclusion around phospholipids generally, particularly polyunsaturated ones, rather than around plasmalogens.
What This Does Not Support
It does not support giving a plasmalogen supplement to an infant, or to a nursing parent with the aim of enriching their milk. No study here tested either. The dietary intervention that has actually been recommended on the basis of this literature is DHA supplementation for mothers with low milk DHA, which is a different nutrient with its own evidence base and its own clinical guidance. Infant feeding decisions belong with a paediatrician or a lactation consultant, and the products discussed elsewhere on this site are formulated and studied in adults.
What the research does establish is that plasmalogens are a normal, variable component of human milk that declines across lactation and reaches the infant brain. That is a genuinely interesting piece of developmental biology. It is not a claim about a product.
Frequently Asked Questions
How much plasmalogen is in human breast milk?
It varies far more than a single figure suggests. In a French cohort of 22 lactating women, milk plasmalogen ranged from 3.4 to 39.2 mg per litre, a more than tenfold spread. Levels also decline as lactation progresses, falling between one month and four months postpartum in a separate study of 39 mother and infant pairs.
Do breast milk plasmalogens improve infant brain development?
The study that tested this most directly found they did not. In 39 mother and infant pairs, milk plasmalogen concentrations were not correlated with infant neurodevelopmental outcomes, though they were associated with lower infant fat mass and higher lean mass. A separate observational study of 65 children linked milk phospholipids generally to preschool cognitive scores, with plasmalogens specifically associated with one subdomain in one sampling window.
Should a nursing parent take a plasmalogen supplement?
No study has tested that. None of the research on milk plasmalogens involved a supplement given to a parent or an infant, and nothing in it supports doing so. The dietary recommendation that has come out of this literature concerns DHA, a different nutrient. Infant feeding decisions belong with a paediatrician or lactation consultant.
References
- Garcia C, Millet V, Coste TC, Mimoun M, Ridet A, Antona C, Simeoni U, Armand M. French mothers milk deficient in DHA contains phospholipid species of potential interest for infant development. Journal of Pediatric Gastroenterology and Nutrition (2011). PMID 21788764
- Ramadurai S, Andrews C, Cheema S, Thomas R, Wagner CL, Sen S. Maternal Predictors of Breast Milk Plasmalogens and Associations with Infant Body Composition and Neurodevelopment. Clinical Therapeutics (2022). PMID 35909001
- Yang MT, Lan QY, Pan C, et al. Long-term cognitive benefits of human milk phospholipids in breastfed children at preschool age: results from MUAI study. European Journal of Nutrition (2025). PMID 40986082
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
